Association between Serum Lactate Dehydrogenase Level and 30-day Mortality in Patients with Intracranial Hemorrhage with Acute Leukemia in the Induction Phase: A Cohort Study

  SFX Search  Permissions and Reprints Abstract

Objectives This study aimed to identify the association between lactate dehydrogenase (LDH) levels and 30-day mortality in patients with intracranial hemorrhage (ICH) with acute leukemia during the induction phase.

Methods This cohort study included patients with acute leukemia with ICH during induction. We evaluated serum LDH levels upon admission. Multivariable Cox regression analyzed the LDH 30-day mortality association. Interaction and stratified analyses based on factors like age, sex, albumin, white blood cell count, hemoglobin level, and platelet count were conducted.

Results We selected 91 patients diagnosed with acute leukemia and ICH. The overall 30-day mortality rate was 61.5%, with 56 of the 91 patients succumbing. Among those with LDH levels ≥ 570 U/L, the mortality rate was 74.4% (32 out of 43), which was higher than the 50% mortality rate of the LDH < 570 U/L group (24 out of 48) (p = 0.017). In our multivariate regression models, the hazard ratios and their corresponding 95% confidence intervals for Log2 and twice the upper limit of normal LDH were 1.27 (1.01, 1.58) and 2.2 (1.05, 4.58), respectively. Interaction analysis revealed no significant interactive effect on the relationship between LDH levels and 30-day mortality.

Conclusions Serum LDH level was associated with 30-day mortality, especially in patients with LDH ≥ 570 U/L.

Keywords lactate dehydrogenase - intracranial hemorrhage - acute leukemia Author Contributions

J.Y.Z. and D.P.L. contributed to the design of the study. J.Y.Z. and D.P.L. contributed to the acquisition of data. J.Y.Z. and Z.S.Y. performed the analyses. J.Y.Z., X.J.S., Y.Z.L., Y.K.Y., M.H.S., Q.L.L., and Y.C.M. contributed to the interpretation of data. J.Y.Z. and Z.S.Y. drafted the manuscript. All authors contributed to the critical revision of the manuscript. All authors read and approved the submitted version.


Data Availability

All relevant summary data are provided in the manuscript text and tables. Further inquiries can be directed to the corresponding author.


Ethics Approval

The study was approved by the Institutional Review Board of the Institute of Hematology and Blood Diseases Hospital.


Consent to Participate

Not applicable.

Publication History

Article published online:
10 April 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

留言 (0)

沒有登入
gif